2006 – KRN951, a highly potent and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has anti-tumor activities and affects functional vascular properties
Home . Ressources . 2006 – KRN951, a highly potent and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has anti-tumor activities and affects functional vascular properties
